Serail Pharmalab India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 77.39%
- Ebitda 85.67%
- Net Worth -18.17%
- Total Assets -19.45%
About Serail Pharmalab India
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH2008PLC184479
- Company No.
184479
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2008
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Serail Pharmalab India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Shah  | Director | 10-Jul-2008 | Current |
| Karnik Parikh | Director | 10-Jul-2008 | Current |
| Nitin Shah | Director | 10-Jul-2008 | Current |
Financial Performance of Serail Pharmalab India.
Serail Pharmalab India Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 77.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serail Pharmalab India?
In 2019, Serail Pharmalab India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmalab India Private Limited.Umesh Shah, Karnik Parikh and 1 more are mutual person
Pharmalab Financial Services Private LimitedKarnik Parikh and Nitin Shah are mutual person
Elomatic-Pharmalab Consulting And Engineering Private LimitedUmesh Shah is a mutual person
Liquipack Systems Private LimitedUmesh Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Serail Pharmalab India?
Unlock and access historical data on people associated with Serail Pharmalab India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serail Pharmalab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serail Pharmalab India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.